Thermo Fisher Scientific Inc. introduced the Gibco CTS DynaXS Single Use Bioreactor, a purpose-built expansion platform designed to help cell therapy developers scale manufacturing with precise control, flexibility, and regulatory readiness. The CTS DynaXS Single Use Bioreactor was designed specifically to address these evolving needs. The stirred-tank, single-use system supports cell expansion across development and early clinical volumes, offering a scalable platform from small process development batches to larger cGMP manufacturing runs.
The CTS DynaXS bioreactor extends Thermo Fisher?s Cell Therapy Systems portfolio, supporting workflows from cell isolation and activation through expansion and downstream processing. This integration enables customers to build modular, scalable manufacturing strategies with unified technical support and regulatory documentation. With CTS DynaXS, a solution designed specifically for cell expansion that aligns with the broader cell therapy manufacturing journey is provided.
The single-use bioreactor offers a broad operating range and flexible design, enabling customers to efficiently scale from small to large production across a wide variety of volumes, applications, and cell types.
